Similarly, Zhang et al. identified a p53-SIRT6-PARP1 axis in colon cancer, where AKT inhibition promoted PARP-1 activation and parthanatos, whereas p53 deletion prevented its induction. This evidence concerns the gene TP53 and colonic neoplasm.